G & B MEDICAL SERVICES LIMITED

G & B MEDICAL SERVICES LIMITED - Company Information

2022-07-012023-06-302023-06-30false07580551G & B MEDICAL SERVICES LIMITED2024-03-2086900iso4217:GBPxbrli:pure075805512022-07-01075805512023-06-30075805512022-07-012023-06-30075805512021-07-01075805512022-06-30075805512021-07-012022-06-3007580551bus:SmallEntities2022-07-012023-06-3007580551bus:AuditExempt-NoAccountantsReport2022-07-012023-06-3007580551bus:FullAccounts2022-07-012023-06-3007580551bus:PrivateLimitedCompanyLtd2022-07-012023-06-3007580551core:WithinOneYear2023-06-3007580551core:AfterOneYear2023-06-3007580551core:WithinOneYear2022-06-3007580551core:AfterOneYear2022-06-3007580551core:ShareCapital2023-06-3007580551core:SharePremium2023-06-3007580551core:RevaluationReserve2023-06-3007580551core:OtherReservesSubtotal2023-06-3007580551core:RetainedEarningsAccumulatedLosses2023-06-3007580551core:ShareCapital2022-06-3007580551core:SharePremium2022-06-3007580551core:RevaluationReserve2022-06-3007580551core:OtherReservesSubtotal2022-06-3007580551core:RetainedEarningsAccumulatedLosses2022-06-3007580551core:LandBuildings2023-06-3007580551core:PlantMachinery2023-06-3007580551core:Vehicles2023-06-3007580551core:FurnitureFittings2023-06-3007580551core:OfficeEquipment2023-06-3007580551core:NetGoodwill2023-06-3007580551core:IntangibleAssetsOtherThanGoodwill2023-06-3007580551core:ListedExchangeTraded2023-06-3007580551core:UnlistedNon-exchangeTraded2023-06-3007580551core:LandBuildings2022-06-3007580551core:PlantMachinery2022-06-3007580551core:Vehicles2022-06-3007580551core:FurnitureFittings2022-06-3007580551core:OfficeEquipment2022-06-3007580551core:NetGoodwill2022-06-3007580551core:IntangibleAssetsOtherThanGoodwill2022-06-3007580551core:ListedExchangeTraded2022-06-3007580551core:UnlistedNon-exchangeTraded2022-06-3007580551core:LandBuildings2022-07-012023-06-3007580551core:PlantMachinery2022-07-012023-06-3007580551core:Vehicles2022-07-012023-06-3007580551core:FurnitureFittings2022-07-012023-06-3007580551core:OfficeEquipment2022-07-012023-06-3007580551core:NetGoodwill2022-07-012023-06-3007580551core:IntangibleAssetsOtherThanGoodwill2022-07-012023-06-3007580551core:ListedExchangeTraded2022-07-012023-06-3007580551core:UnlistedNon-exchangeTraded2022-07-012023-06-3007580551core:MoreThanFiveYears2022-07-012023-06-3007580551core:Non-currentFinancialInstruments2023-06-3007580551core:Non-currentFinancialInstruments2022-06-3007580551dpl:CostSales2022-07-012023-06-3007580551dpl:DistributionCosts2022-07-012023-06-3007580551core:LandBuildings2022-07-012023-06-3007580551core:PlantMachinery2022-07-012023-06-3007580551core:Vehicles2022-07-012023-06-3007580551core:FurnitureFittings2022-07-012023-06-3007580551core:OfficeEquipment2022-07-012023-06-3007580551dpl:AdministrativeExpenses2022-07-012023-06-3007580551core:NetGoodwill2022-07-012023-06-3007580551core:IntangibleAssetsOtherThanGoodwill2022-07-012023-06-3007580551dpl:GroupUndertakings2022-07-012023-06-3007580551dpl:ParticipatingInterests2022-07-012023-06-3007580551dpl:GroupUndertakingscore:ListedExchangeTraded2022-07-012023-06-3007580551core:ListedExchangeTraded2022-07-012023-06-3007580551dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-07-012023-06-3007580551core:UnlistedNon-exchangeTraded2022-07-012023-06-3007580551dpl:CostSales2021-07-012022-06-3007580551dpl:DistributionCosts2021-07-012022-06-3007580551core:LandBuildings2021-07-012022-06-3007580551core:PlantMachinery2021-07-012022-06-3007580551core:Vehicles2021-07-012022-06-3007580551core:FurnitureFittings2021-07-012022-06-3007580551core:OfficeEquipment2021-07-012022-06-3007580551dpl:AdministrativeExpenses2021-07-012022-06-3007580551core:NetGoodwill2021-07-012022-06-3007580551core:IntangibleAssetsOtherThanGoodwill2021-07-012022-06-3007580551dpl:GroupUndertakings2021-07-012022-06-3007580551dpl:ParticipatingInterests2021-07-012022-06-3007580551dpl:GroupUndertakingscore:ListedExchangeTraded2021-07-012022-06-3007580551core:ListedExchangeTraded2021-07-012022-06-3007580551dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-07-012022-06-3007580551core:UnlistedNon-exchangeTraded2021-07-012022-06-3007580551core:NetGoodwill2023-06-3007580551core:IntangibleAssetsOtherThanGoodwill2023-06-3007580551core:LandBuildings2023-06-3007580551core:PlantMachinery2023-06-3007580551core:Vehicles2023-06-3007580551core:FurnitureFittings2023-06-3007580551core:OfficeEquipment2023-06-3007580551core:AfterOneYear2023-06-3007580551core:WithinOneYear2023-06-3007580551core:ListedExchangeTraded2023-06-3007580551core:UnlistedNon-exchangeTraded2023-06-3007580551core:ShareCapital2023-06-3007580551core:SharePremium2023-06-3007580551core:RevaluationReserve2023-06-3007580551core:OtherReservesSubtotal2023-06-3007580551core:RetainedEarningsAccumulatedLosses2023-06-3007580551core:NetGoodwill2022-06-3007580551core:IntangibleAssetsOtherThanGoodwill2022-06-3007580551core:LandBuildings2022-06-3007580551core:PlantMachinery2022-06-3007580551core:Vehicles2022-06-3007580551core:FurnitureFittings2022-06-3007580551core:OfficeEquipment2022-06-3007580551core:AfterOneYear2022-06-3007580551core:WithinOneYear2022-06-3007580551core:ListedExchangeTraded2022-06-3007580551core:UnlistedNon-exchangeTraded2022-06-3007580551core:ShareCapital2022-06-3007580551core:SharePremium2022-06-3007580551core:RevaluationReserve2022-06-3007580551core:OtherReservesSubtotal2022-06-3007580551core:RetainedEarningsAccumulatedLosses2022-06-3007580551core:NetGoodwill2021-07-0107580551core:IntangibleAssetsOtherThanGoodwill2021-07-0107580551core:LandBuildings2021-07-0107580551core:PlantMachinery2021-07-0107580551core:Vehicles2021-07-0107580551core:FurnitureFittings2021-07-0107580551core:OfficeEquipment2021-07-0107580551core:AfterOneYear2021-07-0107580551core:WithinOneYear2021-07-0107580551core:ListedExchangeTraded2021-07-0107580551core:UnlistedNon-exchangeTraded2021-07-0107580551core:ShareCapital2021-07-0107580551core:SharePremium2021-07-0107580551core:RevaluationReserve2021-07-0107580551core:OtherReservesSubtotal2021-07-0107580551core:RetainedEarningsAccumulatedLosses2021-07-0107580551core:AfterOneYear2022-07-012023-06-3007580551core:WithinOneYear2022-07-012023-06-3007580551core:Non-currentFinancialInstrumentscore:CostValuation2022-07-012023-06-3007580551core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-07-012023-06-3007580551core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-07-012023-06-3007580551core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-07-012023-06-3007580551core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-07-012023-06-3007580551core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-07-012023-06-3007580551core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-07-012023-06-3007580551core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-07-012023-06-3007580551core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-07-012023-06-3007580551core:Non-currentFinancialInstrumentscore:CostValuation2023-06-3007580551core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-3007580551core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-3007580551core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-3007580551core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-3007580551core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-3007580551core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-3007580551core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-3007580551core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-3007580551core:Non-currentFinancialInstrumentscore:CostValuation2022-06-3007580551core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-06-3007580551core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-06-3007580551core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-06-3007580551core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-06-3007580551core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-06-3007580551core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-06-3007580551core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-06-3007580551core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-06-3007580551bus:Director12022-07-012023-06-3007580551bus:Director22022-07-012023-06-3007580551bus:Director32022-07-012023-06-3007580551bus:Director42022-07-012023-06-3007580551bus:Director52022-07-012023-06-3007580551core:FurnitureFittingsToolsEquipment2022-06-3007580551core:FurnitureFittingsToolsEquipment2022-07-012023-06-3007580551core:FurnitureFittingsToolsEquipment2023-06-30

Registered Number
07580551
(England and Wales)

Unaudited Financial Statements for the Year ended
30 June 2023

G & B MEDICAL SERVICES LIMITED

Company Information
for the year from 1 July 2022 to 30 June 2023


Directors	HUNTER, Mark, Dr
	LEE, Jiun Lung
	LEOW, May Shen Michelle
	SHARMA, Anil Kumar
	SMYE, Peter, Dr


Registered Address	Suite 37/38 Marshall House 124 Middleton Road
	Morden
	SM4 6RW


Registered Number	07580551 (England and Wales)

G & B MEDICAL SERVICES LIMITED

Balance Sheet as at
30 June 2023

	Notes	2023		2022
		£	£	£	£
Fixed assets
Intangible assets	3		85,000		115,000
Tangible assets	4		18,609		19,768
			103,609		134,768
Current assets
Stocks		97,454		144,381
Debtors		518,695		647,882
Cash at bank and on hand		561,286		239,651
		1,177,435		1,031,914
Creditors amounts falling due within one year	6	(687,027)		(534,782)
Net current assets (liabilities)			490,408		497,132
Total assets less current liabilities			594,017		631,900
Provisions for liabilities	7		(4,683)		(4,683)
Net assets			589,334		627,217
Capital and reserves
Called up share capital			1,504		2,504
Profit and loss account			587,830		624,713
Shareholders' funds			589,334		627,217

The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 20 March 2024, and are signed on its behalf by:

SHARMA, Anil Kumar
Director
Registered Company No. 07580551

G & B MEDICAL SERVICES LIMITED

Notes to the Financial Statements
for the year ended 30 June 2023

1.	Accounting policies

	Statutory information
	The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

	Basis of preparation
	The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

	Turnover policy
	Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.

	Current taxation
	Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.

Current taxation

Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income.

Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.

	Deferred tax
	Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

Deferred tax

Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

	Intangible assets
	Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.

	Amortisation
	The estimated useful lives range as follows: Goodwill- Straight line over 10 years

	Tangible fixed assets and depreciation
	Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life:


	Reducing balance (%)	Straight line (years)
Land and buildings	-	5
Fixtures and fittings	25	-
Vehicles	25	-
Office Equipment	25	-

	Stocks and work in progress
	Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).

2.	Average number of employees


		2023		2022
	Average number of employees during the year	12		17

3.	Intangible assets

	Goodwill	Total
	£	£
Cost or valuation
At 01 July 22	300,000	300,000
At 30 June 23	300,000	300,000
Amortisation and impairment
At 01 July 22	185,000	185,000
Charge for year	30,000	30,000
At 30 June 23	215,000	215,000
Net book value
At 30 June 23	85,000	85,000
At 30 June 22	115,000	115,000

4.	Tangible fixed assets

	Land & buildings	Vehicles	Fixtures & fittings	Office Equipment	Total
	£	£	£	£	£
Cost or valuation
At 01 July 22	12,038	6,450	46,927	14,092	79,507
Additions	-	-	5,280	-	5,280
Disposals	-	(6,450)	-	-	(6,450)
At 30 June 23	12,038	-	52,207	14,092	78,337
Depreciation and impairment
At 01 July 22	5,417	3,049	39,083	12,190	59,739
Charge for year	602	283	1,961	475	3,321
On disposals	-	(3,332)	-	-	(3,332)
At 30 June 23	6,019	-	41,044	12,665	59,728
Net book value
At 30 June 23	6,019	-	11,163	1,427	18,609
At 30 June 22	6,621	3,401	7,844	1,902	19,768

5.	Debtors: amounts due within one year

	2023	2022
	£	£
Trade debtors / trade receivables	444,794	339,131
Other debtors	70,865	306,564
Prepayments and accrued income	3,036	2,187
Total	518,695	647,882

6.	Creditors: amounts due within one year

	2023	2022
	£	£
Trade creditors / trade payables	430,021	492,615
Taxation and social security	84,488	33,578
Other creditors	172,518	-
Accrued liabilities and deferred income	-	8,589
Total	687,027	534,782

7.	Provisions for liabilities

	2023	2022
	£	£
Net deferred tax liability (asset)	4,683	4,683
Total	4,683	4,683